Structural Characterization of the Low-Molecular-Weight Heparin Dalteparin by Combining Different Analytical Strategies

Molecules. 2017 Jun 24;22(7):1051. doi: 10.3390/molecules22071051.

Abstract

A number of low molecular weight heparin (LMWH) products are available for clinical use and although all share a similar mechanism of action, they are classified as distinct drugs because of the different depolymerisation processes of the native heparin resulting in substantial pharmacokinetic and pharmacodynamics differences. While enoxaparin has been extensively investigated, little information is available regarding the LMWH dalteparin. The present study is focused on the detailed structural characterization of Fragmin® by LC-MS and NMR applied both to the whole drug and to its enzymatic products. For a more in-depth approach, size homogeneous octasaccharide and decasaccharide components together with their fractions endowed with high or no affinity toward antithrombin were also isolated and their structural profiles characterized. The combination of different analytical strategies here described represents a useful tool for the assessment of batch-to-batch structural variability and for comparative evaluation of structural features of biosimilar products.

Keywords: LC-MS; NMR; affinity chromatography; dalteparin; low-molecular-weight heparin.

MeSH terms

  • Chromatography, Liquid
  • Dalteparin / chemistry*
  • Heparin Lyase / metabolism
  • Humans
  • Mass Spectrometry
  • Nuclear Magnetic Resonance, Biomolecular

Substances

  • Heparin Lyase
  • Dalteparin